Search research articles
Contact Us
Filters
Showing results (151-160 of 161) with videos related to
Page
of 17
Sort By:
Current Oncology (Toronto, Ont.)
|
September 30, 2021
Brazilian Validation of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group (QLG) Computerised Adaptive Tests (CAT) Core
Gustavo Nader Marta, Tomás Y T de Souza, Alice R N de Souza E Silva, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Efficacy and safety of short-course radiotherapy versus total neoadjuvant therapy in older rectal cancer patients: a randomised pragmatic trial (SHAPERS)
R Saúde-Conde, T Vandamme, M De Backer, et al.
Avian Diseases
|
June 5, 2010
Antigenic and genetic diversity of highly pathogenic avian influenza A (H5N1) viruses isolated in Egypt
Amanda L Balish, C Todd Davis, Magdi D Saad, et al.
Emerging Infectious Diseases
|
June 8, 2007
Genome analysis linking recent European and African influenza (H5N1) viruses
Steven L Salzberg, Carl Kingsford, Giovanni Cattoli, et al.
Plos One
|
February 9, 2010
Single assay for simultaneous detection and differential identification of human and avian influenza virus types, subtypes, and emergent variants
David Metzgar, Christopher A Myers, Kevin L Russell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 19, 2023
Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer
Marion T van Mackelenbergh, Sibylle Loibl, Michael Untch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2023
Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy
Pierre Squifflet, Everardo D Saad, Sibylle Loibl, et al.
Journal of the National Cancer Institute
|
December 5, 2021
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology
Richard M Goldberg, Richard Adams, Marc Buyse, et al.
JAMA Network Open
|
September 21, 2019
Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer
Tomasz Burzykowski, Elisabeth Coart, Everardo D Saad, et al.
Plos One
|
May 31, 2007
Global surveillance of emerging Influenza virus genotypes by mass spectrometry
Rangarajan Sampath, Kevin L Russell, Christian Massire, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 161) with videos related to
Sort By:
Page
of 17
Current Oncology (Toronto, Ont.)
|
September 30, 2021
Brazilian Validation of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group (QLG) Computerised Adaptive Tests (CAT) Core
Gustavo Nader Marta, Tomás Y T de Souza, Alice R N de Souza E Silva, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Efficacy and safety of short-course radiotherapy versus total neoadjuvant therapy in older rectal cancer patients: a randomised pragmatic trial (SHAPERS)
R Saúde-Conde, T Vandamme, M De Backer, et al.
Avian Diseases
|
June 5, 2010
Antigenic and genetic diversity of highly pathogenic avian influenza A (H5N1) viruses isolated in Egypt
Amanda L Balish, C Todd Davis, Magdi D Saad, et al.
Emerging Infectious Diseases
|
June 8, 2007
Genome analysis linking recent European and African influenza (H5N1) viruses
Steven L Salzberg, Carl Kingsford, Giovanni Cattoli, et al.
Plos One
|
February 9, 2010
Single assay for simultaneous detection and differential identification of human and avian influenza virus types, subtypes, and emergent variants
David Metzgar, Christopher A Myers, Kevin L Russell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 19, 2023
Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer
Marion T van Mackelenbergh, Sibylle Loibl, Michael Untch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2023
Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy
Pierre Squifflet, Everardo D Saad, Sibylle Loibl, et al.
Journal of the National Cancer Institute
|
December 5, 2021
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology
Richard M Goldberg, Richard Adams, Marc Buyse, et al.
JAMA Network Open
|
September 21, 2019
Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer
Tomasz Burzykowski, Elisabeth Coart, Everardo D Saad, et al.
Plos One
|
May 31, 2007
Global surveillance of emerging Influenza virus genotypes by mass spectrometry
Rangarajan Sampath, Kevin L Russell, Christian Massire, et al.
Page
of 17